U.S. Patents Awarded to Inventors in New Jersey (Jan. 5)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Jan. 5 -- The following federal patents were awarded to inventors in New Jersey.

*** ExxonMobil Chemical Patents Assigned Patent ALEXANDRIA, Va., Jan. 5 -- ExxonMobil Chemical Patents, Houston, has been assigned a patent (8,344,070) developed by nine co-inventors for "polymer compositions comprising cyclic olefin polymers, polyolefin modifiers, and fillers." The co-inventors are Kevin R. Squire, Kingwood, Texas, Alan J. Oshinski, Friendswood, Texas, Kevin D. Robinson, Houston, Christian Peter Mehnert, Houston, Marsha M. Arvedson, Houston, Beverly J. Poole, Houston, Abhimanyu Onkar Patil, Westfield, N.J., Lisa Saunders Baugh, Ringoes, N.J., and Karla Schall Colle, Houston.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A polymer composition comprises (a) least 40 wt % (based upon the weight of the composition) of a cyclic olefin polymer comprising at least one acyclic olefin and at least 20 wt % of one or more cyclic olefins (based upon the weight of the cyclic olefin polymer), wherein at least a portion of the cyclic olefin polymer has a glass transition temperature of greater than 100.degree. C.; (b) an acyclic olefin polymer modifier in an amount up to 40 wt % (based upon the weight of the composition); and (c) at least 10 wt % (based upon the weight of the composition) of one of more fillers. The polymer composition has a notched Izod impact resistance measured at 23.degree. C. of greater than 100 J/m and a flexural modulus (1% secant method) of greater than 1400 MPa." The patent application was filed on June 20, 2007 (11/820,559). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,070&OS=8,344,070&RS=8,344,070 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Dow Global Technologies Assigned Patent for Polyethylene Compositions, Methods of Making the Same, and Articles Prepared Therefrom ALEXANDRIA, Va., Jan. 5 -- Dow Global Technologies, Midland, Mich., has been assigned a patent (8,344,068) developed by seven co-inventors for "polyethylene compositions, methods of making the same, and articles prepared therefrom." The co-inventors are William J. Michie Jr., Missouri City, Texas, Dane Chang, Sugar Land, Texas, Lonnie G. Hazlitt, Lake Jackson, Texas, Stephanie M. Whited, Charleston, W.Va., Michael A. Kinnan, North Canton, Ohio, Anthony C. Neubauer, Piscataway, N.J., and Thoi H. Ho, Lake Jackson, Texas.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention is related to compositions suitable for the fabrication of pipes, and other articles, with excellent performance properties. The invention provides a composition, comprising a blend, wherein said blend comprises a high molecular weight ethylene-based interpolymer and a low molecular weight ethylene-based interpolymer, and the high molecular weight ethylene-based interpolymer is a heterogeneously branched linear or a homogeneously branched linear ethylene-based interpolymer, and has a density from 0.922 g/cc to 0.929 g/cc, and a high load melt index (I21) from 0.2 g/10 min to 1.0 g/10 min, and the low molecular weight ethylene-based interpolymer is heterogeneously branched linear or a homogeneously branched linear ethylene-based interpolymer, and has a density from 0.940 g/cc to 0.955 g/cc, and a melt index (I2) from 6 g/10 min to 50 g/10 min. The blend has a single peak in an ATREF profile eluting above 30.degree. C., and has a coefficient of viscosity average molecular weight (CM ) less than -0.0032 in the log(calculated Mv) versus elution temperature, said CMv calculated in the range of elution temperatures from 70.degree. C. to 90.degree. C. The Mv is the viscosity average molecular weight." The patent application was filed on Oct. 19, 2007 (12/446,652). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,068&OS=8,344,068&RS=8,344,068 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,344,114) developed by five co-inventors for an antagonists of PCSK9. The co-inventors are Carl P. Sparrow, Westfield, N.J., Ayesha Sitlani, Metuchen, N.J., Shilpa Pandit, Edison, N.J., Jon H. Condra, Doylestown, Pa., and Holly A. Hammond, Telford, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Antagonists of human proprotein convertase subtilisin-kexin type 9 ("PCSK9") are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure." The patent application was filed on Sept. 23, 2011 (13/242,744). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,114&OS=8,344,114&RS=8,344,114 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Siemens Medical Solutions USA Assigned Patent for Detection of Structure in Ultrasound M-mode Imaging ALEXANDRIA, Va., Jan. 5 -- Siemens Medical Solutions USA, Malvern, Pa., has been assigned a patent (8,343,053) developed by four co-inventors for a "detection of structure in ultrasound M-mode imaging." The co-inventors are Shaolei Feng, Plainsboro, N.J., Wei Zhang, Falls Church, Va., Shaohua Kevin Zhou, Plainsboro, N.J., and Jin-hyeong Park, Princeton, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Automated detection of structure is provided in ultrasound M-mode imaging. A coarse and fine search for structure is used. For example, a less noise susceptible initial position or range of positions for a given structure is determined. This position is then refined. The coarse positioning and/or the refined position may use machine-trained classifiers. The positions of other structure may be used in either coarse or fine positioning, such as using a Markov Random Field. The structure or structures may be identified in the M-mode image without user input of a location in the M-mode image or along the line." The patent application was filed on July 20, 2010 (12/839,547). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,053&OS=8,343,053&RS=8,343,053 Written by Neha Bharti; edited by Jaya Anand.

*** Johnson & Johnson Consumer Companies Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Johnson & Johnson Consumer Companies, Skillman, N.J., has been assigned a patent (8,344,031) developed by five co-inventors for "compositions for the treatment of signs of aging." The co-inventors are Eduardo Ruvolo, Plainsboro, N.J., Michael D. Southall, Lawrenceville, N.J., Binoy K. Bordoloi, Bridgewater, N.J., Elvin R. Lukenbach, Flemington, N.J., and Gloria Jean Lukenbach legal representative, Flemington, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention features a method of treating at least one sign of aging on the skin selected from the group consisting of enhancing the elasticity of said skin, enhancing the firmness of said skin, and reducing the appearance of wrinkles or cellulite on the skin, by administering to skin in need of such treatment a composition comprising at least one compound of the formula I or formula II: ##STR00001## wherein R1, R2, R3, R4, and R5 independently, are selected from the group consisting of hydrogen, C.sub.1-C.sub.6 alkyl, C.sub.1-C.sub.6 hydroxyalkyl, or a cosmetically acceptable salt thereof." The patent application was filed on Aug. 3, 2009 (12/534,214). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,031&OS=8,344,031&RS=8,344,031 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,343,990) developed by four co-inventors for "substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment." The co-inventors are Harold B. Wood, Westfield, N.J., Jason W. Szewczyk, New York, Yong Huang, Colonia, N.J., and Alan D. Adams, Cranford, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Substituted cyclopropyl compounds of formula (I) are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119. ##STR00001##" The patent application was filed on March 26, 2009 (12/936,313). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,990&OS=8,343,990&RS=8,343,990 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Johnson & Johnson Consumer Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Johnson & Johnson Consumer, Skillman, N.J., has been assigned a patent (8,343,902) developed by five co-inventors for "low-irritating, clear cleansing compositions with relatively low pH." The co-inventors are Russel M. Walters, Philadelphia, Euen T. Gunn, Trenton, N.J., Lisa Gandolfi, Franklin Park, N.J., Donzel Johnson, Morrisville, Pa., and Emmanuel Anim-Danso, Ewing, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The methods and compositions of this invention relate to compositions having low irritation characteristics in combination with one or more additional characteristics, for example, relatively high clarity, relatively high foaming, and/or combinations thereof, as well as methods of making and using such compositions. These compositions have low pH values and are useful in cleansing the skin." The patent application was filed on June 24, 2010 (12/822,329). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,902&OS=8,343,902&RS=8,343,902 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** State University of New jersey, Silagene Assigned Patent ALEXANDRIA, Va., Jan. 5 -- State University of New jersey, New Brunswicj, N.J., and Silagene, Hillsborough, N.J., have been assigned a patent (8,343,941) developed by Samuel Ian Gunderson, Piscataway, N.J., and Rafal Goraczniak, Hillsborough, N.J., for "compositions and methods for gene silencing." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compositions and methods for modulating the expression of a protein of interest are provided." The patent application was filed on April 8, 2011 (13/082,865). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,941&OS=8,343,941&RS=8,343,941 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** BASF Assigned Patent for Isomerization Catalysts ALEXANDRIA, Va., Jan. 5 -- BASF, Florham Park, N.J., has been assigned a patent (8,343,885) developed by four co-inventors for isomerization catalysts. The co-inventors are Wolfgang Ruettinger, East Windsor, N.J., Ahmad Moini, Princeton, N.J., Bala Ramachandran, Easton, Pa., and Sukwon Choi, Clifton, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Extruded isomerization catalysts comprising MgO, a metal silicate clay binder and a stabilizer and methods of forming such isomerization catalysts are disclosed. Also disclosed are isomerization catalysts that exhibit a fresh isomerization rate and an aged isomerization rate that is at least 50% of the fresh isomerization rate. Embodiments of the isomerization catalysts disclosed herein include metal silicate clay binders that include a layered structure and metal silicate. The metal silicate clay binder may be present in an amount in the range from about 5 wt % to about 20 wt %. Exemplary stabilizers include one or more of ZrO.sub.2, tetravalent rare earth metal and a trivalent rare earth metal. Stabilizers may be present in an amount up to about 40 wt %. One or more improved properties, such as piece crush strength and isomerization performance, are exhibited by the catalyst article." The patent application was filed on Dec. 21, 2010 (12/974,176). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,885&OS=8,343,885&RS=8,343,885 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** State University of New Jersey, University of Medicine and Dentistry of New Jersey, Lehigh University Assigned Patent ALEXANDRIA, Va., Jan. 5 --State University of New Jersey, New Brunswick, N.J., the University of Medicine and Dentistry of New Jersey, Somerset, N.J., and Lehigh University, Bethlehem, Pa., have been assigned a patent (8,343,971) developed by four co-inventors for "pharmacologically-active vanilloid carbamates." The co-inventors are Jeffrey D. Laskin, Piscataway, N.J., Diane E. Heck, Rumson, N.J., Carl Jeffrey Lacey, Schnecksville, Pa., Erik Aponte, Pine Bush, N.Y., Mou-Tuan Huang, Englewood Cliffs, N.J., and Ned D. Heindel, Easton, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This application relates to pharmacologically-active vanilloid compounds which are useful for the treatment of various anti-inflammatory states characterized by inhibition of FAAH, such as, Alzheimer's dementia, Parkinson's disease, depression, pain, rheumatoid arthritis, pathophysiology of mood disorders, multiple sclerosis, and inflammation, or antagonism of TRPV1, such as, for example, Huntington's disease, hypertension, arthritis, allergic airway inflammation, Crohn's disease, ulcerative colitis, and neuropathic pain." The patent application was filed on Sept. 15, 2010 (12/882,351). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,971&OS=8,343,971&RS=8,343,971 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Wyeth LLC Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Wyeth LLC, Madison, N.J., has been assigned a patent (8,343,965) developed by five co-inventors for "compositions containing micronized tanaproget prepared by wet granulation." The co-inventors are Arwinder S. Nagi, Thiells, N.Y., Ramarao Chatlapalli, Hopewell Junction, N.Y., Shamim Hasan, East Elmhurst, N.Y., Rolland W. Carson, Middletown, N.Y., and Mohamed Ghorab, Edison, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compositions, preferably pharmaceutical compositions, containing micronized tanaproget, or pharmaceutically acceptable salt thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, butylated hydroxyanisole, povidone, and magnesium stearate, are provided. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake." The patent application was filed on April 26, 2006 (11/412,014). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,965&OS=8,343,965&RS=8,343,965 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Sunlight Photonics Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Sunlight Photonics, South Plainfield, N.J., has been assigned a patent (8,343,794) developed by Sergey Frolov, Murray Hill, N.J., and Michael Cyrus, Summit, N.J., for a "method and apparatus for manufacturing multi-layered electro-optic devices." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is provided for producing a hybrid multi junction photovoltaic device. The method begins by providing a plurality of planar photovoltaic semi-transparent modules. Each of the modules is a fully functional, thin-film, photovoltaic device and includes first and second conductive layers and at least first and second semiconductor layers disposed between the conductive layers. The first and second semiconductor layers define a junction at an interface therebetween. The method continues by disposing the modules one on top of another and hybridly adhering them to each other. At least one of the modules is configured to convert a first spectral portion of optical energy into an electrical voltage and transmit a second spectral portion of optical energy to another of the junctions that is configured to convert at least part of the second spectral portion of optical energy into an electrical voltage." The patent application was filed on May 11, 2010 (12/777,392). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,794&OS=8,343,794&RS=8,343,794 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Toxcure Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Toxcure, Demarest, N.J., has been assigned a patent (8,343,929) developed by Christopher Shaari, Demarest, N.J., for "treating neoplasms with neurotoxin." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a method of treating a neoplasm using a neurotoxin, preferably botulinum toxin. Neurotoxin administered around a neoplasm acts to decrease the contractile forces of the muscles surrounding a neoplasm which normally squeeze neoplastic cells through efferent channels leaving the neoplasm to distant sites. The present invention also provides a method of administering botulinum toxin at sites distant from the neoplasm, thereby enhancing cellular and humoral immunologic functions, which further contribute to neoplastic cell death. Following administration of botulinum toxin around or distant to a neoplasm as described herein, local, regional, and distant spread of neoplastic cells is reduced or eliminated. Immunomodulation with botulinum toxin is also valuable in treating other diseases that may or may not be associated with cancers, such as viral-induced growths, viral conditions, fungal disease, chronic wounds, graft versus host disease, autoimmune disease, and HIV." The patent application was filed on Nov. 25, 2009 (12/592,540). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,929&OS=8,343,929&RS=8,343,929 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Hoffmann-La Roche Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Hoffmann-La Roche, Nutley, N.J., has been assigned a patent (8,344,027) developed by six co-inventors for "4-dimethylaminobutyric acid derivatives." The co-inventors are Mirjana Andjelkovic, Basel, Switzerland, Simona M. Ceccarelli, Basel, Switzerland, Odile Chomienne, Altkirch, France, Gerald Lewis Kaplan, New York, Patrizio Mattei, Riehen, Switzerland, and Jefferson Wright Tilley, North Caldwell, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula ##STR00001## wherein A.sup.1, A.sup.2, R.sup.1, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments in methods for the treatment of diseases modulated by CPT2 inhibitors." The patent application was filed on April 28, 2009 (12/430,934). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,027&OS=8,344,027&RS=8,344,027 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Eigent Technologies Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Eigent Technologies, Holmdel, N.J., has been assigned a patent (8,344,853) developed by Janice Warner, Holmdel, N.J., Robert Warner, Holmdel, N.J., and Jack Winters, Middletown, N.J., for a "secure RFID system and method." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to a system and method for providing security in an RFID system and provides a secure active RFID architecture that uses a combination of passive and active RFID circuitry and employs authentication and encryption techniques in the processing of data, at rest and over the air. In the method of communicating securely in an RFID system of the present invention, a random number is generated with the passive RFID circuitry. The random number is forwarded to a reader. The reader is authenticated by comparing a first hash value determined from a hash function of the random number generated at the RFID tag and an Authenticated Facility Group ID stored on the RFID tag with a second hash value determined from the hash function of the forwarded random number and an Authenticated Facility Group ID stored in the reader such that if the first hash value matches the second hash value the reader is authenticated. After the reader is authenticated, the tag ID stored at the RFID tag can be revealed. After authentication of the reader, a second layer of security using encryption is provided with the active RFID circuitry." The patent application was filed on May 7, 2007 (11/801,591). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,853.PN.&OS=PN/8,344,853&RS=PN/8,344,853 Written by Kusum Sangma; edited by Anand Kumar.

*** Checkpoint Systems Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Checkpoint Systems, Thorofare, N.J., has been assigned a patent (8,344,891) developed by five co-inventors for a "security hard tag with attachment clip and method for attaching and detaching." The co-inventors are Lawrence Appalucci, Villanova, Pa., Anthony F. Piccoli, West Deptford, N.J., Gary Mazoki, Sewell, N.J., Thomas J. McKeown, Pennsauken, N.J., and James Brodzik, Somerdale, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A security hard tag, uses an attachment clip to couple to an article, such as but not limited to clothing, to be protected and which can only be released from the article by use of an authorized detacher that is inserted into the security hard tag. The attachment clip may include various types of locking mechanisms on its two ends, one end which is permanently secured within the security hard tag housing and the other end which is releasably secured within the housing. Before being releasably secured within the housing, the one end is inserted through or around a portion of an article, or through a security tag loop attached to the article, and then that end is locked into the housing. The detacher uses a cam, either located on the detacher itself or positioned within the security hard tag housing, to interact with the one end of the attachment clip to release the locked end. The housing also includes a security element that may comprise EAS (including AM, RF, EM and microwave), RFID (including LF, HF and UHF), benefit denial (e.g., ink-filled or dye-filled capsules) or any combination thereof. A preferred embodiment of the security hard tag uses all non-ferrous components including its locking mechanism. The non-ferrous composition of the security hard tag, along with the attachment clip design, forms a security hard tag that is strong and lightweight, thereby providing a low impact presentation of a security hard tag with an article." The patent application was filed on June 11, 2009 (12/482,934). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,891.PN.&OS=PN/8,344,891&RS=PN/8,344,891 Written by Kusum Sangma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1110062 (c) 2013 Targeted News Service

[ Back To Technology News's Homepage ]